Receptors, Purinergic P2Y
"Receptors, Purinergic P2Y" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subclass of purinergic P2 receptors whose signaling is coupled through a G-PROTEIN signaling mechanism.
MeSH Number(s)
D12.776.543.750.100.700.720.500
D12.776.543.750.720.700.720.750
D12.776.543.750.810.720.750
Concept/Terms
Receptors, Purinergic P2Y- Receptors, Purinergic P2Y
- P2Y Receptors, Purinergic
- Purinergic P2Y Receptors
- P2Y Purinoceptors
- Purinoceptors, P2Y
- P2Y Purinoceptor
- Purinoceptor, P2Y
Below are MeSH descriptors whose meaning is more general than "Receptors, Purinergic P2Y".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, G-Protein-Coupled [D12.776.543.750.100]
- Receptors, Purinergic [D12.776.543.750.100.700]
- Receptors, Purinergic P2 [D12.776.543.750.100.700.720]
- Receptors, Purinergic P2Y [D12.776.543.750.100.700.720.500]
- Receptors, Neurotransmitter [D12.776.543.750.720]
- Receptors, Purinergic [D12.776.543.750.720.700]
- Receptors, Purinergic P2 [D12.776.543.750.720.700.720]
- Receptors, Purinergic P2Y [D12.776.543.750.720.700.720.750]
- Receptors, Purinergic [D12.776.543.750.810]
- Receptors, Purinergic P2 [D12.776.543.750.810.720]
- Receptors, Purinergic P2Y [D12.776.543.750.810.720.750]
Below are MeSH descriptors whose meaning is more specific than "Receptors, Purinergic P2Y".
This graph shows the total number of publications written about "Receptors, Purinergic P2Y" by people in Harvard Catalyst Profiles by year, and whether "Receptors, Purinergic P2Y" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 2 | 0 | 2 |
| 2015 | 1 | 1 | 2 |
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
Below are the most recent publications written about "Receptors, Purinergic P2Y" by people in Profiles.
-
Proinflammatory P2Y14 receptor inhibition protects against ischemic acute kidney injury in mice. J Clin Invest. 2020 07 01; 130(7):3734-3749.
-
GATA3 germline variant is associated with CRLF2 expression and predicts outcome in pediatric B-cell precursor acute lymphoblastic leukemia. Genes Chromosomes Cancer. 2019 09; 58(9):619-626.
-
Impact of Intravenous P2Y12-Receptor Inhibition with Cangrelor in Patients Presenting with Acute Coronary Syndrome and Cardiogenic Shock - a Case Series. Cell Physiol Biochem. 2017; 42(4):1336-1341.
-
Integrative analysis of DNA copy number, DNA methylation and gene expression in multiple myeloma reveals alterations related to relapse. Oncotarget. 2016 Dec 06; 7(49):80664-80679.
-
Purines in neurite growth and astroglia activation. Neuropharmacology. 2016 05; 104:255-71.
-
Renal intercalated cells sense and mediate inflammation via the P2Y14 receptor. PLoS One. 2015; 10(3):e0121419.
-
A functional landscape of resistance to ALK inhibition in lung cancer. Cancer Cell. 2015 Mar 09; 27(3):397-408.
-
Loss of P2Y14 results in an arresting response to hematological stress. J Clin Invest. 2014 Jul; 124(7):2846-8.
-
Purinergic P2Y14 receptor modulates stress-induced hematopoietic stem/progenitor cell senescence. J Clin Invest. 2014 Jul; 124(7):3159-71.
-
From quiescence to senescence. Cell Cycle. 2014; 13(22):3469-70.